Literature DB >> 20662764

Defining features and exploring chemical modifications to manipulate RNAa activity.

Robert F Place1, Emily J Noonan, Zeno Földes-Papp, Long-Cheng Li.   

Abstract

RNA interference (RNAi) is an evolutionary conserved mechanism by which small double-stranded RNA (dsRNA)--termed small interfering RNA (siRNA)--inhibit translation or degrade complementary mRNA sequences. Identifying features and enzymatic components of the RNAi pathway have led to the design of highly-effective siRNA molecules for laboratory and therapeutic application. RNA activation (RNAa) is a newly discovered mechanism of gene induction also triggered by dsRNAs termed small activating RNA (saRNA). It offers similar benefits as RNA interference (RNAi), while representing a new method of gene overexpression. In the present study, we identify features of RNAa and explore chemical modifications to saRNAs that improve the applicability of RNAa. We evaluate the rate of RNAa activity in order to define an optimal window of gene induction, while comparing the kinetic differences between RNAa and RNAi. We identify Ago2 as a conserved enzymatic component of both RNAa and RNAi implicating that saRNA may tolerate modification based on Ago2 function. As such, we define chemical modifications to saRNAs that manipulate RNAa activity, as well as exploit their effects to design saRNAs with enhanced medicinal properties. These findings reveal functional features of RNAa that may be utilized to augment saRNA function for mechanistic studies or the development of RNAa-based drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662764      PMCID: PMC3413318          DOI: 10.2174/138920110791591463

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  41 in total

1.  Antisense transcription in the mammalian transcriptome.

Authors:  S Katayama; Y Tomaru; T Kasukawa; K Waki; M Nakanishi; M Nakamura; H Nishida; C C Yap; M Suzuki; J Kawai; H Suzuki; P Carninci; Y Hayashizaki; C Wells; M Frith; T Ravasi; K C Pang; J Hallinan; J Mattick; D A Hume; L Lipovich; S Batalov; P G Engström; Y Mizuno; M A Faghihi; A Sandelin; A M Chalk; S Mottagui-Tabar; Z Liang; B Lenhard; C Wahlestedt
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

2.  Moment analysis for kinetics of gene silencing by RNA interference.

Authors:  Yuki Takahashi; Kiyoshi Yamaoka; Makiya Nishikawa; Yoshinobu Takakura
Journal:  Biotechnol Bioeng       Date:  2006-03-05       Impact factor: 4.530

3.  Activating gene expression in mammalian cells with promoter-targeted duplex RNAs.

Authors:  Bethany A Janowski; Scott T Younger; Daniel B Hardy; Rosalyn Ram; Kenneth E Huffman; David R Corey
Journal:  Nat Chem Biol       Date:  2007-01-28       Impact factor: 15.040

4.  Strand-specific 5'-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity.

Authors:  Po Yu Chen; Lasse Weinmann; Dimos Gaidatzis; Yi Pei; Mihaela Zavolan; Thomas Tuschl; Gunter Meister
Journal:  RNA       Date:  2007-12-19       Impact factor: 4.942

5.  Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells.

Authors:  Jiang Han; Daniel Kim; Kevin V Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

6.  Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference.

Authors:  Svetlana Petruk; Yurii Sedkov; Kristen M Riley; Jacob Hodgson; Francois Schweisguth; Susumu Hirose; James B Jaynes; Hugh W Brock; Alexander Mazo
Journal:  Cell       Date:  2006-12-15       Impact factor: 41.582

7.  Small dsRNAs induce transcriptional activation in human cells.

Authors:  Long-Cheng Li; Steven T Okino; Hong Zhao; Deepa Pookot; Robert F Place; Shinji Urakami; Hideki Enokida; Rajvir Dahiya
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

8.  Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.

Authors:  Mouldy Sioud; Gro Furset; Lina Cekaite
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

9.  MicroRNA-373 induces expression of genes with complementary promoter sequences.

Authors:  Robert F Place; Long-Cheng Li; Deepa Pookot; Emily J Noonan; Rajvir Dahiya
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-28       Impact factor: 11.205

10.  Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression.

Authors:  Sven Diederichs; Daniel A Haber
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

View more
  31 in total

1.  Inducing gene expression by targeting promoter sequences using small activating RNAs.

Authors:  Ji Wang; Robert F Place; Victoria Portnoy; Vera Huang; Moo Rim Kang; Mika Kosaka; Maurice Kwok Chung Ho; Long-Cheng Li
Journal:  J Biol Methods       Date:  2015-03-11

Review 2.  RNA activation technique and its applications in cancer research.

Authors:  Xiao-Yu Wang; Long Yuan; Yan-Ling Li; Si-Jie Gan; Lin Ren; Fan Zhang; Jun Jiang; Xiao-Wei Qi
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 3.  Chromatin remodeling by the small RNA machinery in mammalian cells.

Authors:  Long-Cheng Li
Journal:  Epigenetics       Date:  2013-10-22       Impact factor: 4.528

Review 4.  Human RNAi pathway: crosstalk with organelles and cells.

Authors:  Sadegh Azimzadeh Jamalkandi; Esmaeel Azadian; Ali Masoudi-Nejad
Journal:  Funct Integr Genomics       Date:  2013-11-07       Impact factor: 3.410

Review 5.  Small RNA and transcriptional upregulation.

Authors:  Victoria Portnoy; Vera Huang; Robert F Place; Long-Cheng Li
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-05-02       Impact factor: 9.957

6.  Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.

Authors:  Hong Chen; Hai-Xiang Shen; Yi-Wei Lin; Ye-Qing Mao; Ben Liu; Li-Ping Xie
Journal:  Cell Cycle       Date:  2018-08-02       Impact factor: 4.534

7.  Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.

Authors:  Ji Wang; Robert F Place; Vera Huang; Xiaoling Wang; Emily J Noonan; Clara E Magyar; Jiaoti Huang; Long-Cheng Li
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

8.  Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.

Authors:  Mika Kosaka; Moo Rim Kang; Glen Yang; Long-Cheng Li
Journal:  Nucleic Acid Ther       Date:  2012-08-21       Impact factor: 5.486

9.  RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter Transcripts.

Authors:  Pascal Lopez; Kay-Dietrich Wagner; Paul Hofman; Emmanuel Van Obberghen
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

10.  Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.

Authors:  Chenghe Wang; Qiangqiang Ge; Zhong Chen; Jia Hu; Fan Li; Zhangqun Ye
Journal:  Tumour Biol       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.